美托洛尔联合胺碘酮治疗心律失常的临床效果
王海侠1,白彩霞2
(1. 陕西省延安市黄陵县太贤乡卫生院药剂科,陕西 延安,727301; 2.陕西省榆林市榆阳区妇幼保健院内科,陕西 榆林,719000)
浏览次数:73次 下载次数:374次
摘要:
目的 探讨美托洛尔联合胺碘酮治疗心律失常的临床效果。方法 选取我院2015年9月至2016年3月收治的72例心律失常患者为研究对象,采用随机数字表法分为对照组和试验组,每组36 例。对照组患者治疗时予以胺碘酮,试验组患者治疗时予以美托洛尔联合胺碘酮。比较两组患者的临床治疗效果。结果 治疗后,试验组室性心动过速与室性早搏的治疗总有效率为91.67%,明显高于对照组的66.67%(P<0.05)。治疗后,试验组心功能与心绞痛的治疗总有效率为88.89%,明显高于 对照组的63.89%(P<0.05)。结论 对心律失常的患者采用美托洛尔联合胺碘酮治疗,临床效果显著,安全性高,值得临床推广 应用。
关键词:胺碘酮;美托洛尔;心律失常
中图分类号:R541.7文献标志码:A文章编号:2096-1413(2017)27-0036-02
Clinical effect of metoprolol combined with amiodarone in the treatment of arrhythmia
WANG Hai-xia 1, BAI Cai-xia 2
(1. Department of Pharmacy, Health Center of Taixian Town in Huangling County, Yan``an 727301; 2. Department of Internal Medicine, Maternal and Child Care Service Hospital of Yuyang District, Yulin 719000, China)
ABSTRACT: Objective To investigate the curative effect of metoprolol combined with amiodarone in the treatment of arrhythmia. Methods Seventy-two arrhythmia patients admitted in our hospital from September 2015 to March 2016 were selected and divided into control group and experimental group with random table method, with 36 cases in each group. The control group was given amiodarone, and the experimental group was treated with metoprolol combined with amiodarone. The clinical effects of the two groups were compared. Results After treatment, the total effective rate of ventricular tachycardia and premature ventricular contraction treatment in the experimental group was 91.67%, which was higher than 66.67% in the control group (P<0.05). After treatment, the total effective rate of heart function and angina pectoris treatment in the experimental group was 88.89%, which was higher than 63.89% in the control group (P<0.05). Conclusion Metoprolol combined with amiodarone in the treatment of arrhythmia has significant curative effect. It has high safety, which is worthy of clinical application and promotion.
KEYWORDS: amiodarone; metoprolol; arrhythmia
参考文献:
[1] 侯金岭.胺碘酮联合美托洛尔静脉注射治疗快速心律失常的疗效研究[J].中国现代药物应用,2015,9(19):187-188.
[2] 刁树玲,李宗清,马宝新.瑞舒伐他汀对急性冠脉综合征合并心律失常患者炎性因子的影响[J].中国老年学,2015,35(8):2034-2035.
[3] 王琳.胺碘酮联合美托洛尔治疗快速心律失常的有效性研究[J].世界最新医学信息文摘:连续型电子期刊,2016,16(38):102,105.
[4] 陈淑慧.美托洛尔+胺碘酮二联用药治疗快速心律失常疗效及安全性[J].中国实用医药,2015,10(20):148-149.
[5] 宋卫东.胺碘酮联合美托洛尔静脉注射治疗快速心律失常的临床观察[J].中国卫生标准管理,2015,6(30):105-106.
[6] 木提白·吾拉木,汗祖热木·托合提.胺碘酮联合美托洛尔静脉注射治疗快速心律失常的临床观察[J].中国医学创新,2013,18(24):90-91.
[7] 郑永曦,翁金生.胺碘酮联合美托洛尔静脉注射治疗快速心律失常的临床观察[J].心血管病防治知识:学术版,2014,13(2):62-64.
[8] 叶如剑.美托洛尔联合胺碘酮治疗心律失常的临床效果观察[J].海峡药学,2015,27(11):110-111.